[18f] vat
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Oct 3, 2024 (NCT07095205)
Timeline
No events for the selected filters.
Indications
Studied for
Mechanism of action
- Vesicular acetylcholine transporterRadiopharmaceutical
SLC18A3 radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07095205 | Phase 4 | Oct 3, 2024 | National Institute of Mental Health (NIMH), National Institutes of Health (NIH), Stony Brook University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Mental Health (NIMH) | Government | 1 | 0 | 1 | 2024 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2024 |
| Stony Brook University | Academic/Hospital | 1 | 1 | 1 | 2024 |
3 organizations
Page 1 / 1